Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

1 Reason to Buy Exelixis Stock, and 1 Reason to Sell

TheMotleyFool

0 0

1 Reason to Buy Exelixis Stock, and 1 Reason to Sell

Biotech company Exelixis (NASDAQ: EXEL) is not the most famous name in the industry. But quietly, the oncology-focused drugmaker has provided excellent returns this year, even though it's been a bit of a roller-coaster ride.

If Exelixis can continue beating the market, investors would do well to purchase its shares now. But it's not a given that it will. Let's consider one reason the biotech could have a bright future -- and be an excellent investment -- and also why it may not be worth your hard-earned money.